EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Intrarectal Xyloglucan Administration Reduces Disease Severity in the Dextran Sodium Sulfate Model of Mouse Colitis

Edward A Ross iD, Madelyn H Miller iD, Allison Pacheco, Alicia R Willenberg iD, Justine T Tigno-Aranjuez iD, Kaitlyn E Crawford iD

Clinical and Experimental Gastroenterology · 2021-11 · Volume 14 · 429-439

DOI: 10.2147/ceg.s325945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Gastroenterology, 2021-11. Verfasst von Edward A Ross und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, University of Central Florida, Orlando, FL, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DSSdextran sodium sulfateinflammatory bowel diseasetamarindulcerative colitisxyloglucan

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine, University of Central Florida, Orlando, FL, USA.
  • Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.
  • Department of Materials Science and Engineering, College of Engineering and Computer Sciences, University of Central Florida, Orlando, FL, USA.

ORCID-Profile: Edward A Ross, Madelyn H Miller, Alicia R Willenberg, Justine T Tigno-Aranjuez, Kaitlyn E Crawford

Zitieren

APA

Ross, E. A., Miller, M. H., Pacheco, A., Willenberg, A. R., Tigno-Aranjuez, J. T., & Crawford, K. E. (2021). Intrarectal Xyloglucan Administration Reduces Disease Severity in the Dextran Sodium Sulfate Model of Mouse Colitis. Clinical and Experimental Gastroenterology, Volume 14, 429-439. https://doi.org/10.2147/ceg.s325945

Vancouver

Ross EA, Miller MH, Pacheco A, Willenberg AR, Tigno-Aranjuez JT, Crawford KE. Intrarectal Xyloglucan Administration Reduces Disease Severity in the Dextran Sodium Sulfate Model of Mouse Colitis. Clinical and Experimental Gastroenterology. 2021;Volume 14:429-439. doi:10.2147/ceg.s325945

BibTeX
@article{Ross2021,
  author = {Ross, Edward A and Miller, Madelyn H and Pacheco, Allison and Willenberg, Alicia R and Tigno-Aranjuez, Justine T and Crawford, Kaitlyn E},
  title = {Intrarectal Xyloglucan Administration Reduces Disease Severity in the Dextran Sodium Sulfate Model of Mouse Colitis},
  journal = {Clinical and Experimental Gastroenterology},
  year = {2021},
  volume = {Volume 14},
  pages = {429--439},
  doi = {10.2147/ceg.s325945}
}
Kostenlos starten →